Transcript Highlights:

• flood disaster plan and creating public protections against fraudulent bad actors trying to solicit charitable
• flood disaster plan and creating public protections against fraudulent bad actors trying to solicit charitable

Bills: HB4, HB 4

Keywords: redistricting, congressional districts, Texas Legislature, elections, 2020 Census, 997, house, all

Transcript Highlights:

• It would impede the ability of the association to perform its very limited but important charitable purpose
• impose reporting requirements on a private entity, which interferes with our performance and our charitable
• It would impede the ability of the association to perform its very limited but important charitable purpose
• impose reporting requirements on a private entity, which interferes with our performance and our charitable
• It would impede the ability of the association to perform its very limited but important charitable purpose

Keywords: 928, house, all

Summary: The committee held a public hearing on House Bill 233, which would impose transparency and reporting requirements on the New Hampshire Vaccine Association. The prime sponsor, Representative Comto, said the bill and a proposed amendment were intended to increase public access by requiring a physical meeting location, making meetings available online, and publishing a complete list of vaccines and pharmaceutical products purchased. She argued the association should be more transparent because it is involved in vaccine purchasing and public trust is important, especially given controversy around vaccines. Committee members questioned the sponsor about the association’s legal status, who sets vaccine requirements, whether other private entities would be covered, and whether the proposal should instead apply more broadly to all meetings or include recordings. The sponsor said the association was created by the legislature, that childhood vaccine requirements come from DHHS and CDC-related processes, and that she would be open to broader recording requirements. Some members raised concerns about misinformation and whether requiring answers to public questions could be problematic in a contentious policy area. Patrick Miller, executive director of the Vaccine Association, and attorney Mark McHugh testified in opposition. They described the association as a not-for-profit voluntary corporation created by statute in 2002 to serve as a funding mechanism for the state’s universal childhood vaccine purchase program, with no policymaking role and no public funding. They said the association already posts notices, agendas, minutes, and allows public webinar access and comments, while also providing annual audits and reports and other statutory reporting. They argued HB 233 would impose unnecessary administrative costs on a private entity, interfere with its limited charitable purpose, and ultimately increase costs borne by insurers, employers, and consumers. No vote or final action was taken during the hearing.

Transcript Highlights:

• <00:16:48.800> and talking about the spend to pharmacy and talking about the spend to pharmacy
• I'm owner of Columbia Pharmacy in Columbia.
• I've got a short Pharmacy in Colombia.
• An independent pharmacy must than $4.
• > access<01:13:39.360> across helps preserve pharmacy access across helps preserve pharmacy

Keywords: 958, all

Summary: The Medicaid Oversight and Advisory Board met on February 23, 2026, approved the January 12 minutes, and then focused primarily on Kentucky Medicaid’s coverage and potential expansion of GLP-1 drugs, especially for weight loss. Department for Medicaid Services Commissioner Lisa Lee explained that Medicaid currently does not cover drugs for weight loss, anorexia, or weight gain, but the department had filed a regulation to remove that blanket exclusion so GLP-1s could be covered when used for an underlying health condition. She said the administrative regulation review subcommittee found the regulation deficient, and the co-chairs wanted the board to discuss the policy and financing implications before any change. DMS also said it would be open to adding caveats to ensure coverage would not extend to cosmetic weight loss alone. The department provided several data points on current utilization and spending. In 2025, Kentucky Medicaid paid for appetite-stimulating drugs such as Megestrol, Dronabinol, and Marinol, but did not pay for weight-loss drugs. For GLP-1s, DMS said coverage began in 2025 and is limited to FDA-approved medical conditions, with prior authorization requiring a type 2 diabetes diagnosis code and A1C documentation. DMS reported $234.6 million in GLP-1 spending in 2025 before rebates, about 240,931 prescriptions, and said GLP-1s accounted for 7.3% of pharmacy spend in 2024 and 8.3% in 2025. It also said there were 24,844 expansion members and 13,638 non-expansion members using GLP-1s, with spending of about $156 million and $78.5 million respectively, and that 10 pediatric weight-loss prescriptions were covered under EPSDT. The department said outcome analyses, including whether GLP-1 use reduces insulin or other diabetes treatment, are underway and should be completed in a couple of months. Members asked about cost, rebates, and whether the state should wait for more outcomes data before expanding coverage. DMS said average reimbursement to pharmacies was $975 per prescription and the average dispensing fee was $109; it also said 2025 rebate invoices totaled $90.8 million, with $7.6 million collected so far. Several members expressed concern about the high cost and the need to evaluate whether the drugs improve health outcomes before expanding access, while others noted the potential benefits for obesity and diabetes treatment. Some members also discussed whether GLP-1s are effectively being used for weight loss in diabetic patients and whether broader data collection should be used to assess long-term value. After the Medicaid discussion, Eli Lilly executive Tracy Sims presented on obesity as a chronic disease and the economic burden it creates in Kentucky. She said Kentucky’s adult obesity rate is a little over 37%, that obesity is linked to about 200 diseases, and that untreated obesity costs the state billions in GDP and hundreds of millions in state budget impact. She highlighted recent federal access programs for GLP-1s, including a Medicaid-related program that she said could lower the state share of a Zepbound prescription to about $71 per month after federal matching. No votes were taken on the GLP-1 policy question during the meeting, and the main action was the receipt of testimony and discussion of the department’s proposed regulatory change.

Transcript Highlights:

• . pharmacy. pharmacy.
• from the wholesaler to the pharmacy. from the wholesaler to the pharmacy. Okay?
• each pharmacy. Correct. That's correct. each pharmacy. Correct. That's correct.
• or to a mail order pharmacy.
• of independent pharmacies.

Keywords: 928, house, all

Summary: The committee first heard Senate Bill 47, sponsored by Sen. Regina Birdsell at the request of the Insurance Department. The bill would codify the department’s interpretation that a birth mother’s health insurance is the primary coverage for a newborn, unless the mother has no insurance or coverage under an employer-sponsored plan. Birdsell and Insurance Commissioner DJ Benton Court said the measure is a clarification of existing practice and intended to protect vulnerable newborns; a question from Rep. Miles clarified that if a young woman is on her parents’ policy, the newborn would generally be covered under that family coverage. The hearing on SB 47 was then closed. The committee then took up Senate Bill 121, introduced by Grant Bosi for Sen. Kevin Avard, which would require insurers to notify the Insurance Department when they stop writing an entire line of business or, in some cases, Medicare Advantage plans. Commissioner Benton Court said the bill arose from disruption in the Medicare Advantage market, where consumers, brokers, and the department were confused by carriers changing or ending offerings; he said the department wanted a simple notification requirement so it could better advise consumers. Members discussed network adequacy, county-based service areas, and the fact that the bill would make notice a condition of licensure, with possible fines or license action for noncompliance. Witness Paula Rogers of AHIP said her group supported the bill if amended, and the department indicated it would support a change from a 120-day notice period to 90 days to align with state rules; the committee planned to work on an amendment in subcommittee. Finally, the committee heard Senate Bill 247, introduced by Rep. Brian Cole, which would prohibit network exclusion of pharmacies that refuse to dispense prescriptions when PBM reimbursement is below acquisition cost. Cole argued the bill is meant to stop pharmacies from being forced to sell drugs at a loss, describing PBMs as middlemen and saying the measure is a compromise that protects local pharmacies. Members questioned whether consumers would pay more and whether pharmacies voluntarily enter PBM contracts; Cole responded that the bill would let pharmacies refuse unprofitable fills while consumers could still obtain the drug through mail order or other channels. He also said the issue has changed over time because the practice now affects a much larger share of generics and is concentrated among a few PBMs. The hearing remained open as questions continued, with no vote taken in the excerpt.

Transcript Highlights:

• There is charitable giving.
• The Lord loves a cheerful giver, but there is nothing about charitable taking.
• There is charitable giving.
• The Lord loves a cheerful giver, but there is nothing about charitable taking.
• There is charitable giving.

Keywords: 981, all

Summary: The House convened, established a quorum, and approved the journal of Friday, February 6, 2026. Members then proceeded out of order to consider Senate Joint Resolution 8, honoring Colorado’s 2026 Winter Olympians and Paralympians. The resolution was read at length, and members spoke in support of Colorado athletes, training communities, families, and facilities. An amendment correcting an athlete’s state affiliation was adopted, and the resolution passed 63-0 with two excused. Representative Bottoms then asked to co-sponsor the resolution. The chamber also set several bills as special orders for February 9, 2026. It then considered House Bill 1020, concerning colorimetric field drug tests in drug possession cases. Sponsors said the bill addresses unreliable field tests and had support from the Judiciary Committee and stakeholders. The committee report and the bill both passed without opposition. House Bill 1040, concerning the sterilization rights of a person with intellectual and developmental disabilities, was also taken up. Sponsors said the bill seeks to undo a historical harm by removing language that allowed sterilization against a person’s wishes. Two amendments to the committee report were adopted: one narrowing language around an imminent threat to life or health, and another adding a petition clause. The committee report and the bill then passed. Finally, the House considered House Bill 103, which modernizes the Colorado Small Business Recovery and Resiliency Loan Fund. Sponsors said it would better support small businesses facing higher costs and access-to-capital challenges. One amendment to direct 30% of funding to rural counties, veteran-owned businesses, and minority-owned businesses was debated but failed after the sponsor urged a no vote, saying the bill already included distribution metrics and that a fixed percentage was not workable in statute. The bill itself was then discussed further, with concerns raised about state lending programs and the use of the term “equitable,” but the transcript cuts off before final action on the bill is shown.

Transcript Highlights:

• . pharmacy. pharmacy.
• from the wholesaler to the pharmacy. from the wholesaler to the pharmacy. Okay?
• or to a mail-order pharmacy.
• or to a mail-order pharmacy.
• of independent pharmacies.

Keywords: 928, house, all

Summary: The committee first heard Senate Bill 47, sponsored by Senator Regina Birdsell at the request of the Insurance Department. The bill would clarify that a birth mother’s health insurance is the primary policy for a newborn’s care unless the mother has no coverage or no employer-sponsored coverage. Birdsell and Insurance Commissioner DJ Benton Court said the measure simply codifies the department’s long-standing interpretation of existing law. Representative Miles asked whether the coverage would extend to a grandchild if a young woman on her parents’ plan had a baby, and Birdsell said it would. The hearing on SB 47 was then closed. The committee next heard Senate Bill 121, introduced by Grant Bosi for Senator Kevin Avard. The bill requires insurers to notify the Insurance Department when they stop writing an entire line of business or, in some cases, when they change Medicare Advantage offerings. Benton Court said the bill was prompted by disruption in the Medicare Advantage market, where consumers and the department were confused by carriers exiting, changing plans, or narrowing offerings. He said the department does not regulate Medicare Advantage itself, but does license the carriers, and the notice requirement would help the department advise consumers; he also said noncompliance could affect a carrier’s license and could lead to fines. Members discussed the notice period, and the department and AHIP indicated support for changing it from 120 days to 90 days to align with federal timing. The hearing was closed with plans to work on an amendment in subcommittee. Finally, the committee heard Senate Bill 247, introduced by Representative Brian Cole, which would prohibit network exclusion for pharmacies that refuse to dispense prescriptions when PBM reimbursement is below acquisition cost. Cole said the bill is meant to stop pharmacies from being forced to sell at a loss. Members questioned whether pharmacies voluntarily enter PBM contracts, whether the bill would raise consumer prices, and whether it would mainly affect independent pharmacies. Cole and others said the issue has changed over time because PBMs now control a much larger share of the market, and that the bill would let pharmacies refuse loss-making fills and direct patients to mail order instead. The discussion also noted that the bill excludes Medicare and Medicaid and that the current proposal does not create a middle-ground option for patients to pay a premium at the counter.

Transcript Highlights:

• HB 4752 by Landgraf, relating to the eligibility of a charitable organization for an exemption from ad
• solicitation and collection for distributions through gifts, grants, and agreements to nonprofit charitable
• House Bill 3317 by Heffner relates to the relationship between pharmacists or pharmacies and health benefit
• plan issuers or pharmacy benefit managers.

Bills: SB17, SB1569, SB2420, HB5138, HJR161, HB1937, HB3334, HB5444, HB5137, HB361, HB321, HB5447, HB464, HB678, HB2294, HB4172, HB3225, HB1769, HB5394, HB1837, HB1787, HB2271, HB2440, HB5134, HB5149, HB2151, HB2073, HB2186, HB2025, HB1936, HB1777, HB1663, HB 1306, HB 1290, HB1527, HB4802, HB3462, HB2963, HB2462, HB2560, HB644, HB2725, HB2621, HB2588, HB1443, HB1403, HB3032, HB1557, HB1664, HB2811, HB2088, HB2598, HB3062, HB3134, HB3940, HB4027, HB4097, HB4862, HB4170, HB4157, HB4205, HB4279, HB4377, HB4838, HB5424, HB5294, HB4870, HB4763, HB5639, HB4112, HB2275, HB1677, HB5014, HB3848, HB3797, HB3727, HB3709, HB3177, HB3057, HB4176, HB4202, HB2180, HB3528, HB3658, HCR76, HCR127

Keywords: foreign ownership, real property, national security, criminal penalties, civil penalties, personal information, higher education, privacy protection, governing board, institutional security, software applications, mobile devices, age verification, parental consent, data protection, app store regulation, HJR 161, Texas constitutional amendment, voting rights, non-citizen voting

Summary: The House convened with a quorum, received the invocation and pledges, and heard several announcements and recognitions before moving into floor action. Members honored the University of Texas Rio Grande Valley chess team for winning a share of the 2025 President’s Cup, recognized educator Jessica Lopez, and paid memorial tribute to Jennifer Maddenly, along with recognitions for Jeanette Valdez Duran’s food pantry work, TAMACC’s 50th anniversary, and Bernardine Steptoe’s retirement from WFAA. The House also granted permission for committees to meet while the House was in session, set a local consent calendar, and suspended posting rules for a Public Health Committee hearing on SB 2721. The chamber then considered a long series of Senate and House bills, with many passing on record votes. Measures addressed local law enforcement authority (SB 906), veterans highway designation (SB 1229), foster care medical billing (SB 855), massage therapy trafficking safeguards (SB 703), tax ballot language (SB 1025), occupational licensing for people with convictions (SB 1080), lien deadlines (SB 929), liquor sales complaints (SB 1355), higher education application fee waivers (SB 2231), utility data access (SB 1877), pediatric preceptorships (SB 1998), and several House bills on bond forfeiture notice, health workforce coordination, indigent civil commitment representation, consumer transaction cancellations, bird dispersal rules, theft venue for digital property, military grant applications, AI cancer-detection grants, cybersecurity contract language, in-state tuition for military-related programs, utility capital recovery, energy waste advisory oversight, gas utility rate recovery, psychedelic therapy study, teacher retirement funding transparency, pension changes, tax payment plans, and voter registration security. Some measures drew notable debate or amendments, including HB 5247, where a ratepayer-credit amendment failed, and HB 2298, HB 4014, HB 510, HB 561, HB 1128, HB 1904, HB 30, HB 200, HB 3045, and HB 5111, which all passed after recorded votes with varying margins. A major point of contention was SB 2420, the app store age-verification bill, which prompted extended debate over whether the bill should also require app developers to verify users’ ages. Representative Bryant offered an amendment to preserve developer verification obligations, arguing the bill would otherwise shift responsibility away from app makers; the author opposed it, saying the bill’s approach was more workable and raised concerns about First Amendment issues. Multiple points of order were raised and withdrawn during the debate, and the amendment discussion remained unresolved in the excerpt. The House also postponed further consideration of SB 17, SB 552, and SB 2420 at different points, and recessed for lunch after completing a large block of third-reading votes.

Transcript Highlights:

• Item number two is the December 2025 pharmacy formulary recommendations.
• Next item up is the January 2026 pharmacy formulary recommendations.
• Next item up is the January 2026 pharmacy formulary recommendations.
• Moving to the February 2026 pharmacy formulary recommendations.
• more than we're paying our independent pharmacies within the plan?

Summary: The State Insurance Programs Oversight Subcommittee met to review and approve several State Board of Finance actions related to employee benefits and pharmacy coverage. Grant Wallace, Director of the Employee Benefits Division and Office of Property Risk, presented a $280,000 Boston Consulting Group contract to help develop a third-party administration RFP, and the committee approved it. The committee then considered pharmacy formulary recommendations for December 2025, January 2026, and February 2026, along with February 2026 medical drug recommendations. Across the formulary items, Wallace explained that some drugs were being removed from prior authorization requirements, some were being updated to reflect FDA guidance or dosage changes, and others were being left not covered because lower-cost alternatives already exist or clinical evidence was insufficient. Notable changes included removing Skyrizi and Renvoke from the pharmacy formulary in favor of lower-cost biosimilars, adding certain generics, and adding a subcutaneous version of Keytruda for faster administration. The committee approved each set of recommendations by motion and voice vote. Members also raised broader questions about the impact of new drug-pricing programs such as Trump RX, Cost Plus, and other manufacturer discount efforts, as well as concerns about PBM oversight and whether Navitus is complying with state law. Wallace said the department is still studying those issues and working with Navitus to assess pricing opportunities and compliance. Senator Boyd also asked about whether affiliated pharmacies are being paid more than independent pharmacies, noting he had not received a prior response; Wallace was asked to follow up. The meeting concluded with no further business and adjournment.

Transcript Highlights:

• We want to use FEMA funds and also uh charitable contributions.
• use FEMA phone funds and also uh use FEMA phone funds and also uh charitable<00:05:25.960> contributions
• <00:05:26.760> So, charitable contributions. So, charitable contributions.

Keywords: 958, all

Transcript Highlights:

• We're currently the lead on another House bill, and we're working with the Special Forces Charitable
• 20:09.039> the<00:20:09.200> Special<00:20:09.520> Forces<00:20:09.919> Charitable
• with the Special Forces Charitable with the Special Forces Charitable Trust,<00:20:10.720> the

Keywords: 00:20 Roll Call 01:56 HB 7 13:46 HB 7 Vote 17:54 HB 226 24:05 HB 226 Vote 25:13 HB 258 27:13 HB 258 Vote, 958, all

Summary: The House Transportation Committee met for its second meeting of the 2026 session and first took up House Bill 7, sponsored by Representative Hale, which would allow school districts to install stop-arm camera systems on school buses to enforce civil penalties against drivers who illegally pass stopped buses. Hale said the bill had passed the House before, described widespread violations and the danger to children, and outlined the bill’s provisions, including public warning signs, privacy protections, and fines of $300 for a first offense and $500 thereafter. Supporters cited child safety and personal experiences with school-bus-related incidents, while one member opposed the bill on the grounds that it relied too heavily on technology instead of a human officer. The committee then voted and reported HB 7 favorably. The committee next considered House Bill 226, sponsored by Representative Bratcher, which would redirect the $5 fee from Kentucky National Guard specialty license plates from the Kentucky Department of Veterans Affairs to the Kentucky National Guard Association. Bratcher and National Guard representatives said the change would send roughly under $15,000 a year to support readiness, mobilization, and professional development for serving Guard members, and argued that specialty plate revenue should go to the organization tied to the plate. Representative Donworth raised concerns about taking money from the veterans trust fund and suggested a direct budget allocation instead, but the sponsor said the amount was small and that the current arrangement did not return the funds to the Guard. The committee voted to report HB 226 favorably. Finally, the committee heard House Bill 258, sponsored by Representative Payne, as amended by a committee substitute. The bill raises the weight limit for hauling milk from 80,000 to 90,000 pounds and clarifies that the rule applies to both state and federal highways, based on federal treatment of milk as a non-divisible product. After the substitute was adopted, the committee approved the bill, and HB 258 was reported favorably with the committee substitute attached.

Transcript Highlights:

• These pharmacies are required to submit the access to care plans annually by February. 28, the Board
• of Pharmacy is required to collaborate with the boards of Medicine and Osteopathic Medicine regarding
• certification course content the or a pharmacy implemented the provisions of this bill in September
• Pharmacy and BioLogics Solutions.
• They estimate the proof to the Board of Pharmacy of their written collaborative practice agreement.

Transcript Highlights:

• So, I called three different pharmacies So, I called three different pharmacies to<01:07:53.080>
• protecting patients from pharmacy.
• Minnesota Board of Pharmacy. Minnesota Board of Pharmacy.
• <01:23:21.520> and have partnerships with pharmacies and have partnerships with pharmacies
• and support Minnesota pharmacy and support Minnesota pharmacy operations<01:25:20.360> while<

Keywords: 1187, senate, all

Transcript Highlights:

• It's an analysis of pharmacy and medical claims from 2017 to 2023 for individuals living with serious
• And Barney Bishop, Small Business Pharmacies, is waving in support. Is there debate?
• And this is Senate Bill 294, dealing with collaborative pharmacy practice.
• Barney Bishop, Small Business Pharmacies, is in support. And Dr.
• The collaborative pharmacy practice agreement, also known as the CPPA, was passed into law in 2020.

Summary: The Senate Committee on Health Policy met with a quorum and heard five bills. SB 126, on prescription hearing aids, would remove Florida’s prohibition on mailing hearing aids when required tele-audiology testing and procedures are completed before sale. The sponsor said the bill would improve access, especially for people with travel or geographic barriers. The Florida Academy of Audiologists expressed support in concept but said it was still working with the sponsor on an amendment for consumer safety. The committee voted the bill favorably. SB 152 would require hospitals and ambulatory surgical centers to adopt policies using smoke evacuation systems during certain surgical procedures. Supporters, including the Florida Nurses Association and several nurses, described surgical smoke as a workplace and patient safety hazard containing harmful chemicals, viruses, bacteria, and other contaminants, and said evacuation technology is available and already required in some settings. The committee voted the bill favorably. SB 264 would expand step-therapy exemptions for severe mental illness, including certain postpartum and pregnancy-related mental health conditions, so physicians would not have to require patients to fail preferred drugs in specified circumstances. Support came from Otsuka Pharmaceuticals, NAMI Florida, and several medical and pharmacy groups, who argued that delays in effective treatment can worsen crises and increase hospital and crisis-care costs. The committee voted the bill favorably. SB 342 would create a public-records exemption for current and former AHCA employees and certain family information, citing threats and harassment directed at inspectors and regulators. President Gaetz said he generally opposes such exemptions but supported this one because the employees are not elected officials and face real safety risks. The committee voted the bill favorably. SB 294 would limit the Board of Pharmacy’s ability to add heart failure, coronary heart disease, and cardiac rhythm disorders to the list of chronic conditions eligible for collaborative pharmacy practice, keeping those conditions under direct physician management. The Florida Society of Thoracic and Cardiovascular Surgeons, Florida Medical Association, and the Florida chapter of the American College of Cardiology supported the bill, while the Florida Society of Health System Pharmacists opposed it. The committee voted the bill favorably. Senator Trumbull asked to be recorded in support of SB 126 and SB 152, and the meeting adjourned without further business.

Transcript Highlights:

• wagering or horse racing, tribal gaming conducted under the Indian Gaming Regulatory Act, limited charitable
• wagering or horse racing, tribal gaming conducted under the Indian Gaming Regulatory Act, limited charitable
• wagering or horse racing, tribal gaming conducted under the Indian Gaming Regulatory Act, limited charitable
• 11:39.080> Indian Tribal gaming conducted under the Indian Gaming Regulatory Act, limited charitable
• could be defined as a legal charitably could be defined as a legal gray<00:28:50.160> area<00

Bills: SCR145, SCR132, SCR31, SCR110

Keywords: traffic violations, demerit point system, driver license points, traffic safety, hit and run, reckless driving, repeat offenders, recidivism, Department of Transportation, DOT, task force, traffic enforcement, road safety, vehicle code, license suspension, county police, Hawaii transportation, SCR132, Senate Concurrent Resolution, Makakilo Drive Extension

Transcript Highlights:

• Speaker, members, I'm so grateful to recognize Charitable Clinic Action Day at the Capitol.
• So at this time, I ask those with the Texas Association of Charitable Clinics to please stand as you
• For those who don't know, the Texas Association of Charitable Clinics provides quality healthcare services

Transcript Highlights:

• I'm so grateful to recognize Charitable Clinic Action Day at the Capitol.
• They're here in the gallery. today, so at this time I ask those with the Texas Association of Charitable
• For those who don't know, the Texas Association of Charitable Clinics provides quality health care. to

Keywords: 1184, house, all

Transcript Highlights:

• I've um actually board of pharmacy.
• Board of Pharmacy in support. D.
• Uh board of pharmacy in support. D 2029. Uh board of pharmacy in support.
• 704, Alan Shei to the board of pharmacy. 704, Alan Shei to the board of pharmacy.
• <00:48:38.319> Oh,<00:48:38.400> I pharmacy. Governor's message. Oh, I pharmacy.

Keywords: 912, senate, all

Summary: The Senate Committee on Commerce and Consumer Protection held a confirmation hearing on a long list of nominees to state boards and commissions. Early nominees included David Padilla to the State Boxing Commission, Steven Pine to the Board of Dentistry, Deborah McMmen to the Board of Acupuncture, Tiffany Lyn Hmel and Gabriel Aay to the Board of Veterinary Medicine, Nathan Eslin to the Cable Advisory Committee, John Takitani and Tony Lao to the Board of Professional Engineers, Architects, Surveyors and Landscape Architects, John Arbles to the State Board of Public Accountancy, and later nominees to the Board of Psychology, Board of Pharmacy, Hawaii Medical Board, Board of Speech Pathology and Audiology, Board of Chiropractic, Board of Physical Therapy, Board of Private Detectives and Guards, and the Real Estate Commission. Most nominations were for terms expiring in 2027, 2028, or 2029, with one Real Estate Commission term expiring in 2026. Testimony was overwhelmingly in support. DCCA and the relevant boards or commissions generally stood on written testimony supporting each nominee, and many individual supporters also testified, including professional associations, industry representatives, and community members. Several nominees briefly addressed the committee, expressing appreciation and interest in continuing or beginning service. The committee asked a few questions on some nominations, especially about the Real Estate Commission and the Board of Private Detectives and Guards, where members discussed condominium-related complaints, association practices, and whether the board could do more to assist security personnel; the nominee said staffing and authority limits constrained additional training or oversight. For the Real Estate Commission, members also asked about broader housing and market conditions, and the nominee said inventory shortages and housing supply issues remained a major concern. No opposition testimony or contentious votes were described in the transcript. The chair repeatedly asked whether there were questions or additional testimony, and after each nominee the committee generally moved on without objection. The hearing was focused on receiving testimony and evaluating the nominees for later confirmation rather than taking final action during the meeting.

Transcript Highlights:

• And next down is pharmacy fraud.
• Pharmacy fraud. So pharmacy fraud would be a pill mill.
• for the pharmacy that it owns.
• for the pharmacy that it owns.
• I'm here on behalf of the Texas Pharmacy Association to discuss potential waste and abuse by pharmacy

Summary: The Senate Committee on Health and Human Services convened to discuss interim charges regarding fraud, waste, and abuse in Texas human services, particularly focusing on Medicaid and childcare programs. The meeting highlighted the importance of preventing misuse of taxpayer funds, with testimony from various stakeholders emphasizing the need for increased oversight and accountability in these programs. Key points included the alarming rise in healthcare fraud in other states, the necessity for Texas to enhance its fraud prevention measures, and the potential financial repercussions of failing to meet federal compliance standards. Several committee members expressed concerns about the impact of fraud on vulnerable populations, particularly those relying on Medicaid services. Testimonies from experts underscored the effectiveness of Texas's Office of Inspector General (OIG) in combating fraud, yet pointed out existing vulnerabilities, such as inconsistent enforcement and the need for better data sharing among agencies. The discussion also touched on the challenges faced by hospice care providers, with a significant increase in the number of hospices in Texas raising concerns about quality and oversight. The committee heard from various witnesses, including representatives from health plans and advocacy organizations, who provided insights into the complexities of managing Medicaid and the importance of maintaining program integrity. The meeting concluded with a commitment to further explore legislative solutions to enhance oversight and ensure that resources are directed to those in genuine need.

Transcript Highlights:

• where we are going to focus on children's health, disease prevention, screening, treatment, and pharmacies
• I'm a pharmacist, soon to be licensed in Massachusetts, and a professor of pharmacy practice in...
• It doesn't get more local than pharmacies.
• We started 100 patients on pharmacy-based care.
• Under current Massachusetts law, federal law, and FDA policy, state-licensed pharmacies are permitted

Keywords: 995, all

Summary: The Joint Committee on Public Health held a hearing focused on children’s health, disease prevention, screening, treatment, and pharmacy-related bills. The chair explained that the session was for public testimony only, with no votes or decisions taken that day, and outlined the three-minute limit for individual testimony. The committee then heard testimony on a range of bills, including H. 2413 on adding electromagnetic sensitivity to the state’s MAVEN registry, S. 1508 and H. 2433 on creating an amputation prevention task force, H. 2535 and S. 1551 on establishing a naloxone purchase trust fund, S. 1635 on authorizing pharmacists to provide opioid use disorder treatment, H. 2385 on creating a special commission on avian influenza, and S. 1497 on patient safety and non-FDA-approved compounded drugs. Testimony on H. 2413 came largely from advocates and individuals who described electromagnetic sensitivity as a real health condition and argued that adding it to the registry would improve data collection, provider education, and public awareness. Testimony on the amputation prevention task force bills came from the American Diabetes Association and podiatry groups, who said diabetes-related amputations are often preventable, disproportionately affect people of color, and could be reduced through earlier screening, better care coordination, and improved insurance coverage for preventive foot care. On the naloxone trust fund bills, a representative, emergency physician, and nurse testified that hospitals often cannot reliably send overdose patients home with naloxone because of billing and reimbursement barriers, and that a bulk-purchase fund would expand access at no added cost to payers or providers. The committee also heard strong support for S. 1635 from pharmacists and public health researchers, who said community pharmacists could safely initiate and maintain buprenorphine treatment and help close gaps in opioid use disorder care. On H. 2385, a local board of health chair supported a special commission on avian influenza, citing gaps in emergency preparedness and the need for clearer coordination across agencies. On S. 1497, a pharmacy representative opposed restrictions on compounded drugs from outsourcing facilities, warning that changes could reduce access to life-saving medications and harm patient safety. No votes or formal actions were taken during the hearing.

Transcript Highlights:

• AB 1503 is the sunset bill for the California State Board of Pharmacy.
• Current law is often characterized as saying it's a one-to-one ratio, one pharmacy technician to one
• This bill would change the ratio dramatically to four pharmacy technicians to one pharmacist.
• This bill would change the ratio dramatically to four pharmacy technicians to one pharmacist.
• effectively banning pharmacists-owned pharmacies.

Summary: The Assembly Business and Professions Committee heard a full agenda of bills focused on reproductive health, professional licensing and sunset reviews, consumer protection, and business regulation. Early testimony centered on AB 260, which would protect access to medication abortion, mifepristone, and telehealth reproductive care in California; supporters emphasized state protections against federal restrictions, while an opponent argued the bill removed safety safeguards. The committee also heard AB 714 on closing a loophole in regulation of low-cost commercial driving schools, AB 968 on allowing pharmacists to prescribe non-hormonal contraception, AB 671 on streamlining restaurant permitting, AB 1027 on strengthening cannabis product testing oversight, AB 1271 on broadband pricing and speed transparency, and AB 1332 on narrowly allowing medicinal cannabis shipments for seriously ill patients. Several sunset bills were also taken up, including AB 1482 on animal shelter and breeder transparency, AB 1501 on the Podiatric Medical Board and Physician Assistant Board, AB 1502 on the Veterinary Medical Board, AB 1503 on the Board of Pharmacy, and AB 1504 on the Massage Therapy Council. Testimony was largely in support of the measures, with many bills drawing co-sponsors or support from industry, consumer, or professional groups. AB 1503 generated the most sustained opposition, with nurses, physicians, and drug industry representatives objecting to expanded pharmacy technician ratios, standard-of-care language, and therapeutic interchange authority; supporters argued the bill would modernize pharmacy practice and expand access. AB 1504 also drew mixed testimony, with massage therapy groups supporting continuation of the council but raising concerns about proposed public records and governance provisions. AB 1271 drew a policy dispute over whether broadband reporting requirements duplicated federal FCC processes, while supporters argued California needed its own consumer-facing data and complaint system. After quorum was established later in the hearing, the committee began taking roll-call votes. AB 1271, AB 1332, AB 1482, AB 1501, and AB 1502 were all reported out on due-pass motions, with AB 1271 amended and the others generally amended or as introduced as noted. Earlier bills including AB 260, AB 671, AB 714, AB 968, and AB 1027 also received motions and were approved once the quorum was present. The chair repeatedly noted the lack of quorum during the hearing, but once one was secured, the committee completed votes on the agenda items and advanced the measures to Appropriations.